Medtronic Begins Active Portfolio Management Phase
The company's spine business grew in the high single digits for FY 3Q22 as the company prepares to make overall portfolio changes. Feb 25, 2022
NuVasive Ready to Grow Beyond XLIF Roots
The company grew in the high single-digits in 2021 and is ready to expand into other areas of spine as it becomes a comprehensive player. Feb 24, 2022
Smith+Nephew Looks to Regain Momentum in 2022
The company finished 2021 near its pre-pandemic levels but named a new CEO to face mounting challenges in orthopedics. Feb 23, 2022
DJO Primed for Growth Heading into 2022
The company grew +49% in 2021 as it continued integrating its recent acquisitions ahead of its spin-off as Enovis at the end of 1Q22. Feb 23, 2022
Amplitude Surgical Growth Spurred by Foot and Ankle Segment
The company's knee and hip replacement sales remain impacted by surgical restrictions, but its foot and ankle line continued its ascent. Feb 21, 2022
Globus Medical Nears $1 Billion in Orthopedic Sales
The company grew over 21% in 2021 as it took share from larger competitors. Globus expects to surpass the $1 billion mark in 2022. Feb 18, 2022
Seikagaku Keeps Momentum in International Markets
The company grew in the mid-single digits for FY3Q21 as market recovery in Japan and abroad has helped Seikagaku increase sales volume. Feb 09, 2022
Zimmer Biomet Lowers Expectations for 2022
The company grew in the low double digits for 2021 compared to 2020. but expects 2022 to be flat at best, given the market environment. Feb 08, 2022
Zimmer Biomet’s Spin-off of ZimVie to Complete March 1, 2022
Zimmer Biomet will complete the spin-off of its spine and dental divisions on March 1, 2022, with the debut of ZimVie. Feb 07, 2022
Stryker Enters 2022 With Momentum
Stryker reported 4Q21 orthopedic sales of $2.4 billion, +13.8% vs. 4Q20. For the full year of 2021, the company’s orthopedic... Jan 28, 2022
